Publications by authors named "Hannah Vetter"
Background: This study aimed to evaluate the association of antiphospholipid antibodies (aPL) and conventional markers of coagulation with ischemic and bleeding risk in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).
Methods: In this prospective two-center observational cohort study, patients with AF and an indication for oral anticoagulation (OAC) were enrolled after PCI. Blood was drawn on day 1-3 after PCI.
Article Synopsis
- High on-clopidogrel platelet reactivity (HPR) is linked to ischemic risks in patients undergoing percutaneous intervention (PCI), especially those with atrial fibrillation (AF) who are on oral anticoagulants.
- In a study involving 159 patients, only 1% exhibited HPR, while the majority had low platelet reactivity, indicating overall low aggregability in this group.
- The results suggested that traditional HPR definitions may not be suitable for these patients, and that monitoring platelet aggregation might help assess bleeding risks rather than ischemic events.
Background: High on-clopidogrel platelet reactivity (HPR) following percutaneous coronary intervention (PCI) is associated with increased ischemic risk. It is unclear whether conventional definitions of HPR apply to patients with concomitant oral anticoagulation (OAC). This study aimed to compare the performance of multiple platelet aggregometry (MEA) and thrombelastography (TEG) to detect HPR in patients with atrial fibrillation (AF) and indication for an OAC.
View Article and Find Full Text PDFIntroduction: Liver dysfunction can derive from severe sepsis and might be associated with poor prognosis. However, diagnosis of septic liver dysfunction is challenging due to a lack of appropriate tests. Measurement of maximal liver function capacity (LiMAx test) has been successfully evaluated as a new diagnostic test in liver resection and transplantation.
View Article and Find Full Text PDF